Skip to main content

Table 2 Characteristics of 14 variants identified in 11 patients with intellectual disability/developmental delay

From: Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene

Pt

G

Age

Gene

Inh

Reference

CDS

Protein

Or

N/R

Pat

AF

GERP

CADD

SI

Po

MT

Co

PR

MC

1

F

16Y

EFNB1

XL

NM_004429.4

c.640C > T

p.(Gln214Ter)

d

N

LP

5.2

38.0

D

2

F

1Y3M

MECP2

XL

NM_004992.3

c.808C > T

p.(Arg270Ter)

d

R

P

3.8

36.0

D

3

M

17Y

ATRX

XL

NM_000489.3

c.6257 T > C

p.(Leu2086Ser)

m

N

LP

5.5

31.0

D

D

D

D

4

M

1Y7M

ATRX

XL

NM_000489.3

c.6679G > T

p.(Asp2227Tyr)

d

N

LP

5.7

33.0

D

D

D

D

5

M

1Y3M

NAA10

XL

NM_003491.3

c.248G > A

p.(Arg83His)

ma

N

LP

5.0

34.0

D

D

D

D

D

D

ANKRD11

AD

NM_013275.5

c.884G > A

p.(Ser295Asn)

d

N

VUS

5.9

31.0

D

D

D

D

N

T

6

F

8Y4M

DHCR7

AR

NM_001163817.1

c.1376G > A

p.(Trp459Ter)

p

N

P

5.1

42.0

D

c.901C > A

p.(His301Asn)

m

N

LP

3.6

25.7

D

D

D

D

D

D

7

F

9Y4M

LAMA1

AR

NM_005559.3

c.1711_1712del

p.(Ala571Pro fsTer8)

p

N

VUS

c.2755G > C

p.(Gly919Arg)

m

N

LP

1.85e-3

5.5

29.2

D

D

D

D

D

D

8

M

4Y2M

NFIX

AD

NM_001271043.1

c.613C > T

p.(Gln205Ter)

d

N

P

4.6

39.0

D

9

M

3Y3M

UBE3A

AD

NM_000462.3

c.403G > T

p.(Glu135Ter)

d

N

P

5.8

37.0

D

10

M

1Y

ARID1B

AD

NM_001346813.1

c.6212 T > A

p.(Ile2071Asn)

d

N

LP

5.4

32.0

D

D

D

D

D

D

11

F

5Y5M

PTPRD

AD?

NM_002839.3

c.5534 + 1G > A

p.(Ser1845Arg fsTer2)

d

N

−10.0

D

  1. Note: Pt patient, G gender, Y years, M months, Inh inheritance pattern, XL X-linked, AD autosomal dominant, AR autosomal recessive, Or origin, m maternal, p paternal, d de novo, N novel, R reported, Pat pathogenicity, P pathogenic, LP likely pathogenic, VUS variant with uncertain significance, GERP GERP++RS score, D “probably damaging” in Polyphen2 or “deleterious” in other software, SI SIFT, Po PolyPhen2, MT MutationTaster, Co Condel, PR PROVEAN, MC M-CAP;a, the variant arose de novo in the patient’s mother